Trial Profile
Phase II trial of GLG-801 in patients with chronic lymphatic leukemia in combination with existing chemotherapies
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Mar 2016
Price :
$35
*
At a glance
- Drugs GLG 801 (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- Sponsors GLG Pharma
- 04 Mar 2016 New trial record